Table 2.
Bone marrow involvement in PET–CT and/or bone marrow biopsy according to lymphoma subtypes
| Hodgkin Lymphoma | Involvement in bone marrow biopsy | ||
| Involvement in PET–CT | Positive | Negative | Total |
| Positive | 5 | 9 | 14 |
| Negative | 1 | 30 | 31 |
| Total | 6 | 39 | 45 |
| Follicular lymphoma | Involvement in bone marrow biopsy | ||
| Involvement in PET–CT | Positive | Negative | Total |
| Positive | 6 | 4 | 10 |
| Negative | 13 | 23 | 36 |
| Total | 19 | 27 | 46 |
| DLBCL | Involvement in bone marrow biopsy | ||
| Involvement in PET–CT | Positive | Negative | Total |
| Positive | 7 | 4 | 11 |
| Negative | 12 | 104 | 116 |
| Total | 19 | 108 | 127 |
| NHL (other lymphomas) | Involvement in bone marrow biopsy | ||
| Involvement in PET–CT | Positive | Negative | Total |
| Positive | 18 | 3 | 21 |
| Negative | 16 | 21 | 37 |
| Total | 34 | 24 | 58 |